Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sporolac Plus
- Development stage
- Phase 3
- Lead developer
- Sanzyme Biologics
- Modality
- Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Administration
- Oral, Topical
01
Overview
Sporolac Plus is a multi-strain probiotic formulation designed to restore and maintain a healthy microbial balance in the body. It typically contains a combination of beneficial bacteria and yeast, specifically **Lactobacillus acidophilus**, **Lactobacillus rhamnosus**, **Bifidobacterium longum**, **Bacillus coagulans** (formerly known as Lactobacillus sporogenes), and the yeast **Saccharomyces boulardii**. This combination works by competitively inhibiting the growth of pathogenic microorganisms, producing antimicrobial substances such as lactic acid and bacteriocins, and enhancing the host's immune response. While primarily used for gastrointestinal health and the treatment of diarrhea, it has also been investigated for oral health applications, such as reducing the levels of cariogenic bacteria like *Streptococcus mutans* in the dental plaque of high-risk individuals.
- Brand names
- Sporolac Plus
- Other names
- probiotic mouth rinseSporolac Plus powder
Beyond the preview
Go deeper on Sporolac Plus.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Sporolac Plus.